Terms: = Breast cancer AND Neurokinin AND Prognosis
4 results:
1. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
[TBL] [Abstract] [Full Text] [Related]
2. TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells.
Wang L; Wang N; Zhang R; Dong D; Liu R; Zhang L; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Life Sci; 2020 Sep; 256():117674. PubMed ID: 32380077
[TBL] [Abstract] [Full Text] [Related]
3. Triple Negative breast cancer: How neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach.
Muñoz M; Rosso M; Coveñas R
Mini Rev Med Chem; 2020; 20(5):408-417. PubMed ID: 31721701
[TBL] [Abstract] [Full Text] [Related]
4. Oncogenic and metastatic properties of preprotachykinin-I and neurokinin-1 genes.
Singh AS; Caplan A; Corcoran KE; Fernandez JS; Preziosi M; Rameshwar P
Vascul Pharmacol; 2006 Oct; 45(4):235-42. PubMed ID: 16901764
[TBL] [Abstract] [Full Text] [Related]
